Ken Kitayama Selected Research

Ken Kitayama Research Topics

4	Glaucoma 12/2023 - 01/2023
3	Atherosclerosis 10/2007 - 10/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 12/2006
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 10/2023
1	Angle-Closure Glaucoma (Glaucoma, Angle Closure) 10/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Diabetes Mellitus 01/2023
1	Endophthalmitis (Ophthalmia) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 10/2007
1	Coronary Disease (Coronary Heart Disease) 06/2006
1	Atherosclerotic Plaque (Atheroma) 06/2006

2	N- (4- (4- tert- butoxycarbonylpiperazin- 1- yl)phenyl)- (2- chloro- 5- nitrophenyl)carboxamideIBA 10/2007 - 12/2006
2	HDL LipoproteinsIBA 10/2007 - 12/2006
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 11/2023
1	acceleratory factor from growth hormone (AcG)IBA 10/2023
1	Niacin (Nicotinic Acid)FDA LinkGeneric 01/2023
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2023
1	SteroidsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	R-154716IBA 10/2007
1	LipidsIBA 12/2006
1	Apolipoproteins E (ApoE)IBA 12/2006
1	Scavenger Receptors (Scavenger Receptor)IBA 12/2006
1	ApolipoproteinsIBA 12/2006
1	CholesterolIBA 06/2006
1	Cholesterol Esters (Cholesteryl Esters)IBA 06/2006
1	CollagenIBA 06/2006
1	pactimibeIBA 06/2006
1	Sterol O-AcyltransferaseIBA 06/2006
1	Angiotensin Receptor AntagonistsIBA 10/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2005

2	Trabeculectomy (Trabeculoplasty) 12/2023 - 11/2023
1	Therapeutics 01/2022